Business Wire

Interactive Brokers Providing Access to Tel Aviv Stock Exchange

Del

Interactive Brokers Group, Inc. (IEX:IBKR), an automated global electronic broker, announced that IBKR institutional and retail clients can now trade stocks on the Tel Aviv Stock Exchange (TASE). IBKR will connect clients to TASE via a banking intermediary based in Israel.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190311005436/en/

Thomas Peterffy, Founder, Chairman and CEO of Interactive Brokers (Photo: Business Wire)

Thomas Peterffy, Founder, Chairman and CEO of Interactive Brokers (Photo: Business Wire)

The “gateway to the world’s markets”, Interactive Brokers serves more than 607,000 clients worldwide and operates on more than 120 exchanges in 32 countries. The company enables clients to fund their account in 23 currencies and trade assets from a single account in multiple currencies, including the Israeli shekel.

“Interactive Brokers is truly a global money management platform. We aim to provide clients with unparalleled access to the world’s financial markets, including smaller markets that larger financial institutions often don’t serve,” said Thomas Peterffy, CEO of Interactive Brokers. “Due to our international scope and advanced technology, we can offer opportunities for investors to access smaller markets efficiently and cost effectively.”

“Providing our clients with access to the Tel Aviv Stock Exchange extends IBKR’s global reach and lets both retail and professional clients invest in Israeli companies,” he said.

Ittai Ben-Zeev, CEO of TASE, said, “We are pleased with IBKR’s decision to facilitate TASE trading for their clients worldwide. Since Interactive Brokers is one of the world’s leading international brokerage firms, we view their move to provide their clients better access to TASE as a vote of confidence in the Israeli capital market and TASE. We have set the enhancement of TASE’s international ties and footprint as a strategic priority and are dedicated to providing global firms, such as IBKR, the infrastructure and services necessary to best serve the global investor's needs.”

Mr. Ben-Zeev added, “We welcome international investors and encourage them to take part in Israel’s economic success. This is a direct result of our strategic plan and aspiration to encourage international investors to trade on TASE, to expand trading volumes and improve liquidity in the Israeli market. Over the past year, we have taken significant steps to further facilitate international investor activity on TASE. We launched co-location services to accommodate high-frequency/low latency trading. We have contracted with the global network provider, BSO, for direct connectivity between London and TASE and we have significantly eased the criteria for remote TASE membership. We hope to see more global entities follow IBKR’s lead in easing their clients’ access to TASE."

Products that can be traded on the TASE can be viewed here: https://www.interactivebrokers.com/en/index.php?f=2222&exch=tase&showcategories=

About Interactive Brokers Group, Inc.

Interactive Brokers Group affiliates provide automated trade execution and custody of securities, commodities and foreign exchange around the clock on over 120 markets in numerous countries and currencies, from a single IBKR Integrated Investment Account to clients worldwide. We service individual investors, hedge funds, proprietary trading groups, financial advisors and introducing brokers. Our four decades of focus on technology and automation has enabled us to equip our clients with a uniquely sophisticated platform to manage their investment portfolios at the lowest cost according to Barron’s Best Online Brokers review, February 25, 2019. We strive to provide our clients with advantageous execution prices and trading, risk and portfolio management tools, research facilities and investment products, all at low or no cost, positioning them to achieve superior returns on investments.

About the Tel Aviv Stock Exchange (TASE)

The Tel Aviv Stock Exchange Ltd. was founded in September 1953. The TASE Group, which consists of the Tel Aviv Stock Exchange, the TASE Clearing House, TASE Nominee company and the MAOF Derivatives Clearing House, provides local and international investors with comprehensive securities trading and clearing services across multiple asset classes, including stocks, corporate bonds, government bonds, Exchange Traded Products, and derivatives.

TASE fulfills a major role in the Israeli economy and its growth. It is the home turf on which corporate Israel raises capital to finance investment and operations. As Israel’s sole regulated securities and derivatives exchange, TASE is also home to the Israeli financial community.

In April 2017, the Knesset ratified an amendment of the Securities Law enabling changes to TASE's ownership structure and in September 2017 the District Court ratified TASE’s demutualization. It is now a for-profit enterprise, in which membership is separated from share ownership.

For further information visit: www.tase.co.il

Contact information

For Interactive Brokers Group, Inc.
Investors:
Nancy Stuebe, 203-618-4070
or
Media:
Kalen Holliday, 203-913-1369
or
media@ibkr.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Workiva Named Best-In-Class Cloud Service Provider at UK Cloud Awards17.5.2019 12:00:00 CESTPressemelding

Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, was named the Best-In-Class Cloud Service Provider by the UK Cloud Awards 2019 at a ceremony here last night. Now in its sixth year, the UK Cloud Awards recognise innovation and excellence in the cloud industry by showcasing leading companies, customers and individuals in the United Kingdom. Workiva was recognised for its Wdesk platform that helps organisations consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders. Workiva, the global leader in XBRL and Inline XBRL, is also streamlining how customers comply with the European Securities and Markets Authority's mandate for Inline XBRL for European Single Electronic Format (ESEF) reporting. More than 5,000 EU issuers will be required to use ESEF taxonomy for their annual financial reports, ending on or after Jan

Novaremed Presents Top-Line Results from Phase 2a Diabetic Neuropathic Pain Study of NRD.E1 at NeuPSIG 201917.5.2019 10:13:00 CESTPressemelding

Novaremed AG, a clinical-stage Swiss biopharmaceutical company, today announced a poster presentation highlighting the top-line results from a Phase 2a (Proof of Concept) study of NRD.E1 for the treatment of diabetic neuropathic pain (DNP). The poster presentation took place at the 7th International Congress on Neuropathic Pain Meeting (NeuPSIG) in London, UK on May 9-11, 2019. “This was our first communication at a leading neuropathic pain-focused event. Novaremed’s lead drug, NRD.E1 is a non-opioid small molecule for the treatment of neuropathic pain. The results of our Phase 2a in patients with DNP showed clinically relevant treatment benefit from NRD.E1 across multiple primary and secondary endpoints, providing a strong scientific foundation for advancing the development of NRD.E1 into the upcoming global Phase 2b study in DNP,” said Sara Mangialaio, Head of R&D and Chief Medical Officer of Novaremed AG. “NRD.E1 has the potential to address a major unmet medical need in DNP.” Poste

WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology17.5.2019 09:38:00 CESTPressemelding

The 11th WIN Symposium in Precision Oncology will be held in Paris, France on June 23-24, 2019. ASCO® endorsed for the past 11 years, the WIN symposium will deliver an exciting line-up of speakers in Paris (France) on June 23-24, 2019 to discuss Innovation and Global Deployment of Precision Oncology. The current status of Precision Oncology across the globe will be examined with the exceptional participation of the chairmen of the event, Richard L. Schilsky, Chairman WIN Consortium(*), Senior Vice-President and Chief Medical Officer of ASCO, and Josep Tabernero, Vice Chairman WIN Consortium, President of ESMO and Director of Vall d’Hebron Institute of Oncology, Spain. Global experience will be shared: Optimizing Patient Enrollment and Efficacy of Precision Oncology Clinical Trials at UT MD Anderson Cancer Center, USA Decision Support for Precision Oncology: Evolving from Monotherapy to Genomically Informed Combinations, UT MD Anderson Cancer Center, USA The Value of Personalized Medici

Corsearch Acquires Principium Trademark Watch and Domain Services Businesses17.5.2019 08:00:00 CESTPressemelding

Corsearch, the global brand creation, clearance, and protection leader, is pleased to announce the acquisition of the Principium Strategies trademark watch and domain services businesses, the brand protection subsidiary of Ladas and Parry LLP, a leader in global intellectual property law. The acquisition is effective immediately, solidifying and expanding Corsearch’s full-service trademark solutions offering for clients and brands globally. Principium is Corsearch’s third acquisition since becoming a standalone company in January 2018. The acquisition brings Corsearch’s employee count to more than 350 operating in 28 locations worldwide and adds valuable industry expertise and additional capabilities to Corsearch. “This is another really exciting acquisition for our business and a step forward in the evolution of Corsearch,” said Stephen Stolfi, Chief Commercial Officer of Corsearch. “Principium has provided clients with industry-leading trademark watching services for over 80 years an

CNT Among SAP’s "Best of the Best"17.5.2019 08:00:00 CESTPressemelding

Since 2005, SAP is honoring the best of the best SAP projects yearly in Europe, Middle East and Africa. In 2018, 280 customers from 15 markets submitted their regional Gold Award-winning projects. CNT Management Consulting from Vienna won Bronze twice – together with its customers HOERBIGER and TANNPAPIER – a happy day for CNT’s CEO Andreas Doerner. "We are now on the podium for the second time with two projects – thanks to the trust of our customers." The SAP Quality Awards EMEA were presented at an exceptionally festive ceremony in Heidelberg Castle (Baden-Wuerttemberg), and only twelve SAP customers were able to take home the most wanted trophies that were presented by SAP Presidents Brian Duffy (EMEA North) and Hartmut Thomsen (Middle and Eastern Europe). The jury evaluated the projects according to the ten SAP quality principles and the question of whether the respective project could fulfill the expectations of its clients. HOERBIGER - Category Business Transformation Headquarter

EVER Pharma acquires Amneal Deutschland GmbH and extends its commercial presence in Europe17.5.2019 07:25:00 CESTPressemelding

EVER Pharma Holding Ges.m.b.H (Austria) announced today that it has completed the acquisition of Amneal Deutschland GmbH, a subsidiary of Amneal Pharmaceuticals that operates the company's commercial operations in Germany. Amneal Deutschland already distributes several EVER Pharma products in Germany and is a strongly established player in the German hospital market. The acquired entity will be rebranded to EVER Pharma GmbH. “This acquisition represents another milestone in the expansion of EVER Pharma’s commercial footprint in Europe. With this new operation, EVER Pharma extends its portfolio in Germany and establishes a solid platform for the growth of its portfolio and pipeline” commented Georges Kahwati, General Manager of EVER Pharma. “We are pleased to establish another EVER affiliate in one of the key European markets in line with our strategy of establishing our own business presence in core markets.” added Julia Hillebrand, Managing Director and Owner. About EVER Pharma: EVER